Form 4 for TXG 10x Genomics, Inc.
Accepted 2021-08-04 00:00:00 ET · period of report 2021-08-02 · accession 0001209191-21-049653 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-08-04 | 2021-08-02 | TXG | STUELPNAGEL JOHN R | Dir | S - Sale | $180.42 | -5,000 | 390.5K | -1% | -$902.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-08-02 | S | D | 400 | $182.74 | 386,916 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $182.35 to $183.13. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2021-08-02 | S | D | 100 | $184.99 | 386,616 | D | — | — | |
| 3 | Common | Class A Common Stock | 2021-08-02 | S | D | 200 | $183.90 | 386,716 | D | — | — | (F7) This transaction was executed in multiple trades at prices ranging from $183.62 to $184.18. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2021-08-02 | S | D | 1,100 | $181.47 | 387,316 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $180.98 to $181.93. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 5 | Common | Class A Common Stock | 2021-08-02 | S | D | 960 | $180.33 | 388,416 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $179.98 to $180.92. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 6 | Common | Class A Common Stock | 2021-08-02 | S | D | 1,140 | $179.53 | 389,376 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $178.98 to $179.955. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 7 | Common | Class A Common Stock | 2021-08-02 | S | D | 1,100 | $178.48 | 390,516 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $177.98 to $178.955. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |